Goldman Sachs Maintains Buy on Merck & Co, Raises Price Target to $160

Benzinga · 1d ago
Goldman Sachs analyst Terence Flynn maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $140 to $160.